ASSESSING RESPONSE TO TACRINE USING THE FACTOR-ANALYTIC STRUCTURE OF THE ALZHEIMERS-DISEASE ASSESSMENT SCALE (ADAS) COGNITIVE SUBSCALE

被引:18
作者
OLIN, JT
SCHNEIDER, LS
机构
[1] UNIV SO CALIF, SCH MED, DEPT PSYCHIAT & BEHAV SCI, LOS ANGELES, CA 90033 USA
[2] UNIV SO CALIF, SCH GERONTOL, DEPT NEUROL, LOS ANGELES, CA USA
关键词
ALZHEIMERS DISEASE ASSESSMENT SCALE; DEMENTIA; COGNITION; MEMORY TESTS;
D O I
10.1002/gps.930100905
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
A factor analysis of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASc), the primary cognitive outcome measure in most clinical trials of drugs for Alzheimer's disease, was undertaken to test whether factor scores are differentially sensitive to change in a placebo-controlled 30-week trial of the cholinesterase inhibitor tacrine. The factor analysis identified three factors: language, memory and praxis, a factor structure similar to an earlier report. All three factors showed worsening for placebo patients acid improvements for tacrine patients, with significant between-group treatment effects. None of the factors was significantly more sensitive to change than another, suggesting that tacrine affects a range of cognitive function.
引用
收藏
页码:753 / 756
页数:4
相关论文
共 18 条
[1]
ASSOCIATION BETWEEN QUANTITATIVE MEASURES OF DEMENTIA AND OF SENILE CHANGE IN CEREBRAL GREY MATTER OF ELDERLY SUBJECTS [J].
BLESSED, G ;
TOMLINSON, BE ;
ROTH, M .
BRITISH JOURNAL OF PSYCHIATRY, 1968, 114 (512) :797-+
[2]
Cattell RB., 1978, SCI USE FACTOR ANAL, DOI 10.1007/978-1-4684-2262-7_5
[3]
A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF TACRINE FOR ALZHEIMERS-DISEASE [J].
DAVIS, KL ;
THAL, LJ ;
GAMZU, ER ;
DAVIS, CS ;
WOOLSON, RF ;
GRACON, SI ;
DRACHMAN, DA ;
SCHNEIDER, LS ;
WHITEHOUSE, PJ ;
HOOVER, TM ;
MORRIS, JC ;
KAWAS, CH ;
KNOPMAN, DS ;
EARL, NL ;
KUMAR, V ;
DOODY, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18) :1253-1259
[4]
TACRINE IN ALZHEIMERS-DISEASE [J].
EAGGER, SA ;
LEVY, R ;
SAHAKIAN, BJ .
LANCET, 1991, 337 (8748) :989-992
[5]
A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE [J].
FARLOW, M ;
GRACON, SI ;
HERSHEY, LA ;
LEWIS, KW ;
SADOWSKY, CH ;
DOLANURENO, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18) :2523-2529
[6]
MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[7]
CEREBRAL BLOOD-FLOW IN DEMENTIA [J].
HACHINSKI, VC ;
ILIFF, LD ;
ZILHKA, E ;
DUBOULAY, GH ;
MCALLISTER, VL ;
MARSHALL, J ;
RUSSELL, RWR ;
SYMON, L .
ARCHIVES OF NEUROLOGY, 1975, 32 (09) :632-637
[8]
DIFFERENTIAL VALIDITY OF PSYCHOMETRIC TESTS IN DEMENTIA OF THE ALZHEIMER TYPE [J].
IHI, R ;
FROLICH, L ;
DIERKS, T ;
MARTIN, EM ;
MAURER, K .
PSYCHIATRY RESEARCH, 1992, 44 (02) :93-106
[9]
FACTOR STRUCTURE AND RELIABILITY OF THE ALZHEIMERS-DISEASE ASSESSMENT SCALE IN A MULTICENTER TRIAL WITH LINOPIRDINE [J].
KIM, YS ;
NIBBELINK, DW ;
OVERALL, JE .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 1994, 7 (02) :74-83
[10]
A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
KNAPP, MJ ;
KNOPMAN, DS ;
SOLOMON, PR ;
PENDLEBURY, WW ;
DAVIS, CS ;
GRACON, SI ;
APTER, JT ;
LAZARUS, CN ;
BAKER, KE ;
BARNETT, M ;
BAUMEL, B ;
EISNER, LS ;
CASTELLS, B ;
BOLOURI, R ;
BENNETT, D ;
FORCHETTI, C ;
LEVIN, A ;
BLASS, JP ;
NOLAN, KA ;
GAINES, ER ;
RELKIN, N ;
BORISON, RL ;
DIAMOND, B ;
CELESIA, GG ;
ROSS, AP ;
DEXTER, J ;
DOODY, R ;
LIPSCOMB, L ;
KREITER, K ;
DUBOFF, EA ;
BLOCK, P ;
MARSHALL, D ;
WESTERGAARD, N ;
EARL, NL ;
WYNE, SV ;
HINMANSMITH, E ;
FARLOW, M ;
HENDRIE, HC ;
CARESS, JA ;
FARMER, M ;
HARPER, JE ;
FERGUSON, J ;
FOSTER, NL ;
BARBAS, NR ;
BLUEMLEIN, LA ;
GELB, DJ ;
BERENT, S ;
GIORDANI, B ;
GREENWALD, M ;
BERGMAN, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :985-991